|
|
 |
|
Viewing report
|
|
|
|
Transdermal Drug Delivery: Patches, Gels, Active Systems, Therapeutics, Markets & Forecasts
Greystone Associates, Aug 2009
Advances in synthetic materials and skin patch designs have led to transdermal drug delivery products that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Transdermal drug delivery patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Growth is being driven by several factors – factors with strong demographic and population trend underpinnings. Transdermal patch developers are expanding the type and number of prescription and OTC therapies and treatments that can be effectively administered to patients and consumers. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. The ecosystem that supplies patch manufacturing and testing services is an important factor in the development of new transdermal patches. The report is structured to provide transdermal drug delivery sector participants with all of the information necessary to identify marketing factors and business opportunities for transdermal drug delivery products.
This report was carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of the publication is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.
Feature Summary
- Provides detailed analysis of marketed transdermal delivery products and assessments of 36 pipeline candidates
- Analyzes transdermal delivery market segments, therapeutic indications, market dynamics and market demographics
- Assesses therapeutic demand drivers and risk factors
- Analyzes design factors, material selection issues, technologies and market development issues
- Charts product data, market share, and forecasts by drug class to 2012
- Profiles transdermal delivery sector participants, their product development activities, business strategies, and corporate alliances and affiliations
- Assesses the importance of pharma-device alliances and design partnerships on pen injector products
- Evaluates the impact of economic, technology, and regulatory factors
Customers who bought this item also bought
Active Transdermal Delivery
Transdermal Skin Patches: Markets and Opportunities 2009
Drug Delivery: Active Transdermal Delivery Systems
Transdermal Drug Delivery - Technologies, Markets, and Companies
Transdermal Pain Management: Markets, Demand Factors, Forecasts, and Opportunities
Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition
The Top 40 Transdermal Drug Delivery Technology Companies Worldwide
U.S. Transdermal Drug Delivery Markets
Drug Delivery for Self-Administration Report - Technologies, Combination
Nanoparticle Drug Delivery Market Report
Pediatric Drug Delivery
Injectable Drug Delivery
|
|
|
|
